Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

IntelliLung · Intelligent Lung Support for Mechanically Ventilated Patients in the Intensive Care Unit

HORIZONStatus: SIGNED1 September 202231 August 2027EU funding €5,980,347Call HORIZON-HLTH-2021-DISEASE-04

Invasive mechanical ventilation (MV) is one of the most important and life-saving therapies in the intensive care unit (ICU). In most severe cases, when MV alone is insufficient, extracorporeal lung support (ELS) is initiated. However, MV is recognised as potentially harmful, because inappropriate MV settings in ICU patients are associated with organ damage, contributing to disease burden. Studies revealed that MV is often not properly provided despite clear evidence and guidelines. Furthermore, treatment decisions by the healthcare providers, especially regarding MV and ELS, often remain incomprehensible to the patients and their relatives, since flow of information from caregivers to patients is challenged by a number of factors, including limited time and resources, communication problems as well as patients? capacity to comprehend and memorise information. The project proposed herein aims at clinically validating and extending our IntelliLung Artificial Intelligence Decision Support System (AI-DSS) designed to optimise MV and ELS settings to improve the care of ICU patients, alongside caregiver-patient communication. Thereby, best practice evidence-based MV and ELS within safer therapy corridors for longer periods, faster weaning from MV, and improved survival could be achieved - even in non-experienced hands. Additionally, this project will improve the information flow from caregivers to patients and relatives in the ICU setting. Therefore, we will develop a digital solution that allows automatic generation of an extensive plain-language information package for patients and their relatives, communicating highly individualised information on diseases and knowledge-based disease-management strategies, thus facilitating high-quality current and subsequent care through health literacy empowerment and patient-centredness. We will perform a retrospective and prospective multi-centre study to validate our IntelliLung AI-DSS and the patient information software.

Consortium · 20 organisations

coordinator

TECHNISCHE UNIVERSITAET DRESDEN

DE · €1,797,787

participant

FUNDACIO INSTITUT D'INVESTIGACIÓ I INNOVACIÓ PARC TAULI

ES · €71,500

thirdParty

DEMCON LIFE SCIENCES & HEALTHEINDHOVEN B.V.

NL

thirdParty

Demcon Life Sciences & Health Maastricht B.V.

NL

participant

BETTER CARE SL

ES · €517,810

participant

EUROPEAN SOCIETY OF ANAESTHESIOLOGY AND INTENSIVE CARE AISBL

BE · €101,875

thirdParty

FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PRINCESA

ES

thirdParty

CORPORACIO SANITARIA PARC TAULI DE SABADELL

ES

associatedPartner

INSEL GRUPPE AG

CH

participant

SERVICIO MADRILENO DE SALUD

ES · €231,250

participant

DEMCON MACAWI RESPIRATORY SYSTEMS BV

NL · €478,625

thirdParty

DEMCON INNOVATION & TECHNOLOGY B.V.

NL

thirdParty

IRCCS AZIENDA OSPEDALIERA METROPOLITANA

IT

participant

INSTITUT MIHAJLO PUPIN

RS · €497,375

participant

THE CLEVELAND CLINIC FOUNDATION

US · €120,000

participant

UNIVERSITA DEGLI STUDI DI GENOVA

IT · €256,000

participant

WAS HAB' ICH? GEMEINNUTZIGE GMBH

DE · €605,125

participant

FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.

ES · €97,500

participant

PANSTWOWY INSTYTUT MEDYCZNY MINISTERSTWA SPRAW WEWNETRZNYCH I ADMINISTRACJI

PL · €205,500

participant

INSTITUT FUR ANGEWANDTE INFORMATIK (INFAI) EV

DE · €1,000,000

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.